Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

Ni Vincent, Nasta Sunita D, Barta Stefan K, Schuster Stephen J, Chong Elise A, Svoboda Jakub, Morrissette Jennifer J D, Barlev Ashley, Bagg Adam, Priore Salvatore F, Landsburg Daniel J

机构信息

School of Arts and Sciences, University of Pennsylvania, Philadelphia.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.

出版信息

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

DOI:10.3324/haematol.2024.286560

PMID:39605216

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959230/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ca/11959230/9e23427e54a0/1101023.fig1.jpg

相似文献

[1]

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

Haematologica. 2025-4-1

[2]

Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.

Ann Palliat Med. 2020-7

[3]

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.

Oncologist. 2021-7

[4]

External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.

Hematology. 2022-12

[5]

[The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].

Zhonghua Xue Ye Xue Za Zhi. 2018-9-14

[6]

[A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].

Zhonghua Xue Ye Xue Za Zhi. 2019-2-14

[7]

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.

Ann Hematol. 2017-11

[8]

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Haematologica. 2014-12

[9]

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

Haematologica. 2009-10-1

[10]

A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 /CD79B diffuse large B-cell lymphoma.

Cancer Med. 2024-2

本文引用的文献

[1]

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma.

BMC Cancer. 2023-10-19

[2]

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.

Blood Adv. 2023-12-12

[3]

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.

Signal Transduct Target Ther. 2023-4-10

[4]

A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients.

Haematologica. 2020-11-1

[5]

Prognostic Significance of Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

J Clin Oncol. 2019-9-9

[6]

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

J Clin Oncol. 2018-12-3

[7]

TP53 mutation and survival in aggressive B cell lymphoma.

Int J Cancer. 2017-6-26

[8]

P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.

Mod Pathol. 2017-2

[9]

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Br J Haematol. 2015-4-24

[10]

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

Blood. 2014-8-26

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献